Cargando…
Remarkable Response of Hairy Cell Leukemia Variant to Single-Agent Cladribine
Classical hairy cell leukemia (cHCL) and related mature lymphoid B-cell neoplasms including hairy cell leukemia variant (HCLv) and splenic diffuse red pulp lymphoma (SDRPL) are a rare subset of lymphoid neoplasms. cHCL accounts for around 2% of all leukemias and is characterized by a peripheral smea...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9188828/ https://www.ncbi.nlm.nih.gov/pubmed/35698717 http://dx.doi.org/10.7759/cureus.24976 |
_version_ | 1784725461645918208 |
---|---|
author | Otieno, Steve B Ogbeide, Osarenren |
author_facet | Otieno, Steve B Ogbeide, Osarenren |
author_sort | Otieno, Steve B |
collection | PubMed |
description | Classical hairy cell leukemia (cHCL) and related mature lymphoid B-cell neoplasms including hairy cell leukemia variant (HCLv) and splenic diffuse red pulp lymphoma (SDRPL) are a rare subset of lymphoid neoplasms. cHCL accounts for around 2% of all leukemias and is characterized by a peripheral smear with large lymphoid cells with cytoplasmic projections giving the cells a hairy appearance, splenomegaly, and cytopenias. Majority of cHCL cases harbor a BRAFV600E mutation. cHCL usually responds well to single-agent purine analogs. HCLv is even rarer and constitutes around 0.4% of lymphoid malignancies. Unlike cHCL, HCLv is less responsive to standard single-agent purine analogs and typically does not harbor the BRAFV600E mutation. The “hairy cells,” splenomegaly, and cytopenias are common in both. We report a case of a patient with HCLv who was treated with a single purine analog and achieved a near-complete response. |
format | Online Article Text |
id | pubmed-9188828 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Cureus |
record_format | MEDLINE/PubMed |
spelling | pubmed-91888282022-06-12 Remarkable Response of Hairy Cell Leukemia Variant to Single-Agent Cladribine Otieno, Steve B Ogbeide, Osarenren Cureus Oncology Classical hairy cell leukemia (cHCL) and related mature lymphoid B-cell neoplasms including hairy cell leukemia variant (HCLv) and splenic diffuse red pulp lymphoma (SDRPL) are a rare subset of lymphoid neoplasms. cHCL accounts for around 2% of all leukemias and is characterized by a peripheral smear with large lymphoid cells with cytoplasmic projections giving the cells a hairy appearance, splenomegaly, and cytopenias. Majority of cHCL cases harbor a BRAFV600E mutation. cHCL usually responds well to single-agent purine analogs. HCLv is even rarer and constitutes around 0.4% of lymphoid malignancies. Unlike cHCL, HCLv is less responsive to standard single-agent purine analogs and typically does not harbor the BRAFV600E mutation. The “hairy cells,” splenomegaly, and cytopenias are common in both. We report a case of a patient with HCLv who was treated with a single purine analog and achieved a near-complete response. Cureus 2022-05-13 /pmc/articles/PMC9188828/ /pubmed/35698717 http://dx.doi.org/10.7759/cureus.24976 Text en Copyright © 2022, Otieno et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Oncology Otieno, Steve B Ogbeide, Osarenren Remarkable Response of Hairy Cell Leukemia Variant to Single-Agent Cladribine |
title | Remarkable Response of Hairy Cell Leukemia Variant to Single-Agent Cladribine |
title_full | Remarkable Response of Hairy Cell Leukemia Variant to Single-Agent Cladribine |
title_fullStr | Remarkable Response of Hairy Cell Leukemia Variant to Single-Agent Cladribine |
title_full_unstemmed | Remarkable Response of Hairy Cell Leukemia Variant to Single-Agent Cladribine |
title_short | Remarkable Response of Hairy Cell Leukemia Variant to Single-Agent Cladribine |
title_sort | remarkable response of hairy cell leukemia variant to single-agent cladribine |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9188828/ https://www.ncbi.nlm.nih.gov/pubmed/35698717 http://dx.doi.org/10.7759/cureus.24976 |
work_keys_str_mv | AT otienosteveb remarkableresponseofhairycellleukemiavarianttosingleagentcladribine AT ogbeideosarenren remarkableresponseofhairycellleukemiavarianttosingleagentcladribine |